Results 131 to 140 of about 15,580 (252)

Evaluating the impact of store‐and‐forward teledermatology in a German university hospital setting

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background Increasing waiting times for dermatology appointments demand innovative digital solutions. Teledermatology provides an efficient means of remote diagnosis and management of skin diseases. Patients and Methods This study evaluated the implementation and impact of a store‐and‐forward teledermatology platform at a university hospital ...
Teodora Pumnea, Maximilian Deußing, Natalie Evenschor, Ann‐Christin Cirkel, Elke Sattler, Michael J. Flaig, Lars E. French, Christian Greis   +7 more
wiley   +1 more source

Relationship and probabilistic stratification of Eczema Area and Severity Index and objective Scoring Atopic Dermatitis severity scores for atopic dermatitis

British Journal of Dermatology, 2018
G. Hurault, M.E. Schram, E. Roekevisch, P.I. Spuls, R.J. Tanaka   +4 more
openaire   +3 more sources

Increased Levels of Inflammatory Proteins, Including TARC/CCL17, in Skin of AD Patients During JAK Inhibitor Treatment

Clinical &Experimental Allergy, Volume 55, Issue 3, Page 260-263, March 2025.
Celeste M. Boesjes, Lian F. van der Gang, Daphne S. Bakker, C. F. den Hartog Jager, Marlies de Graaf, Marjolein S. de Bruin‐Weller, Femke van Wijk, Edward F. Knol   +7 more
wiley   +1 more source

A 1% glycopyrronium bromide cream for topical treatment of severe primary axillary hyperhidrosis in adolescents: safety, local tolerability, systemic exposure and efficacy from an open‐label phase II study

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Primary axillary hyperhidrosis (PAHH) results from dysregulation of the autonomic nervous system and typically begins during puberty. Treatment options for adolescents remain limited. This open‐label phase II study evaluated the safety, local tolerability, systemic exposure, and efficacy of 1% GPB cream over 8 weeks in
Rolf‐Markus Szeimies, Ana Kilic, Hubert Reich, Birgit Berger, Erik Schulze zur Wiesche, Leonie Litzka, Katharina Schramm, Susanne Heimstaedt‐Muskett, Clarissa Masur   +8 more
wiley   +1 more source

Efficacy and Safety of Crisaborole Ointment 2% in Chinese Patients Aged ≥ 2 Years with Mild to Moderate Atopic Dermatitis

Dermatology and Therapy
Introduction Atopic dermatitis (AD) is a chronic immuno-inflammatory skin disease. Crisaborole ointment, 2%, is a nonsteroidal phosphodiesterase 4 inhibitor approved for the treatment of mild to moderate AD.
Lin Ma, Xiaohua Tao, Sujun Liu, Hao Cheng, Ruihua Fang, Yan Zhao, Amy Cha, Gerardo A. Encinas, Yangmei Zhou, Yujie Deng, Jianzhong Zhang   +10 more
doaj   +1 more source

Eczema and Lung Function Across the Life Course: A Systematic Review

Clinical &Experimental Allergy, EarlyView.
Mohammed K. Alghasham, Vincent Newton, E. Haydn Walters, Shyamali Dharmage, Jennifer Perret, Caroline Lodge, Dinh Bui, Adrian J. Lowe, Diego J. Lopez   +8 more
wiley   +1 more source

Applying artificial intelligence to optical coherence tomography for detection and subtyping of basal cell carcinoma

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Basal cell carcinoma (BCC) is the most common cancer and a major public health burden. Noninvasive techniques such as optical coherence tomography (OCT) may reduce unnecessary biopsies and enable earlier detection. However, effective OCT interpretation requires expertise.
Vinzent Kevin Ortner, Jon Holmes, Peter Alshede Philipsen, Gavrielle Rebecca Untracht, Stine Regin Wiegell, Tomos Gwyn Williams, David Cristinacce, Merete Haedersdal   +7 more
wiley   +1 more source

Inborn errors of immunity in children with neuroinflammation

Developmental Medicine &Child Neurology, EarlyView.
Abstract Inborn errors of immunity (IEIs), an expanding group of monogenic disorders with diverse clinical manifestations, are increasingly recognized to include neuroinflammatory disease. Examples of diseases included under this umbrella are Aicardi–Goutières syndrome, deficiency of adenosine deaminase 2, familial haemophagocytic lymphohistiocytosis ...
Eppie M Yiu, Dilan Dissanayake, Jessie Cunningham, Helen Branson, Ori Scott, E Ann Yeh   +5 more
wiley   +1 more source

Genetic testing in paediatric neurological disorders

Developmental Medicine &Child Neurology, EarlyView.
In this study 390 paediatric patients with neurological disorders underwent genetic testing via exome sequencing, commercial panel, in‐house epilepsy, and movement disorder gene panels. Exome sequencing provides the highest diagnostic yield, and severe developmental delay and hypotonia predicted pathogenic variants in the exome sequencing cohort ...
Wafa Bani Uraba, Byoung Chan Lee, Shekeeb S. Mohammad, Katrina Fisk, Michael Buckley, Russell C. Dale, Tony Roscioli, Paediatric Neurogenomic Working Group, Manoj P. Menezes, Sachin Gupta, Christopher Troedson, Esther Tantsis, Richard Webster, Bruce Bennetts, Deepak Gill, Kavitha Kothur   +15 more
wiley   +1 more source

CD36‐mediated lipid rewiring in the metabolic adaptation of tumour ecosystems

The FEBS Journal, EarlyView.
Nutrient deprivation drives a lipid‐centric shift in tumour metabolic symbiosis and signalling network. CD36 functions as a bidirectional bridge, transferring fatty acids from stromal donors (adipocytes, CAFs) to the ecosystem tumour‐ and microenvironment‐dependently.
Anna Sebestyén, Viktória Varga, Fatime Szalai, Risa Miyaura, Nóra Förhécz, Bálint Csikós, Rebeka Gelencsér, Zsófia Gábriel, Timea Komlódi, Katalin Dezső, Ildikó Krencz, Dorottya Moldvai   +11 more
wiley   +1 more source